Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2021 Nov 24;18(1):118.
doi: 10.1186/s12954-021-00568-3.

The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services

Yesenia Aponte-Melendez  1   2 , Pedro Mateu-Gelabert  3 , Chunki Fong  3 , Benjamin Eckhardt  4 , Shashi Kapadia  5 , Kristen Marks  5
Affiliations
Randomized Controlled Trial

The impact of COVID-19 on people who inject drugs in New York City: increased risk and decreased access to services

Yesenia Aponte-Melendez et al. Harm Reduct J. .

Abstract

Background: While people who inject drugs (PWID) are vulnerable to the adverse outcomes of events like COVID-19, little is known regarding the impact of the current pandemic on PWID. We examine how COVID-19 has affected PWID in New York City across four domains: substance use, risk behaviors, mental health, and service utilization.

Methods: As part of a randomized trial to improve access to HCV treatment for PWID, we recruited 165 participants. Eligibility criteria included detectable HCV RNA and recent drug injection. The present cross-sectional analysis is based on a subsample of 106 participants. We compared responses between two separate samples: 60 participants interviewed prior to the pandemic (pre-COVID-19 sample) and 46 participants interviewed during the pandemic (COVID-19 sample). We also assessed differences by study group [accessible care (AC) and usual care (UC)].

Results: Compared to the pre-COVID-19 sample, those interviewed during COVID-19 reported higher levels of mental health issues, syringe reuse, and alcohol consumption and greater reductions in syringe-service programs and buprenorphine utilization. In the analysis conducted by study group, the UC group reported significantly higher injection risk behaviors and lower access to buprenorphine treatment during COVID-19, while during the same period, the AC group reported lower levels of substance use and injection risk behaviors.

Conclusion: The current study provides insight on how COVID-19 has negatively affected PWID. Placing dispensing machines of harm-reduction supplies in communities where PWID live and increasing secondary exchange, mobile services, and mail delivery of supplies may help maintain access to lifesaving supplies during big events, such as COVID-19. Trial registration ClinicalTrials.gov NCT03214679. Registered July 11 2017. https://clinicaltrials.gov/ct2/show/NCT03214679 .

Keywords: Big events; COVID-19; HCV; New York City; People who inject drugs.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no competing interests.

References

    1. Collyer S, Huq S, Washington K, Wimer C. Spotlight on COVID-19. https://www.robinhood.org/wp-content/themes/robinhood/images/poverty-tra... (2020). Accessed 1 Feb 2021.
    1. Parker K, Minkin R, Bennet J. Economic fallout from COVID-19 continues to hit low er-income Americans hardest. https://www.kff.org/coronavirus-covid-19/issue-brief/mental-health-and-s... (2020). Accessed 1 Feb 2021.
    1. Rozenfeld Y, Beam J, Maier H, Haggerson W, Boudreau K, Carlson J, Medows R. A model of disparities: risk factors associated with COVID-19 infection. Int J Equity Health. 2020;19(1):1. - PMC - PubMed
    1. Saladino V, Algeri D, Auriemma V. The psychological and social impact of Covid-19: new perspectives of well-being. Front Psychol. 2020;2(11):2550. - PMC - PubMed
    1. Centers for Disease Control and Prevention. COVID Data Tracker. https://covid.cdc.gov/covid-data-tracker/#datatracker-home. Accessed 20 May 2021.

Publication types

Substances

Associated data